Surgery Partners Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +13.3% | +9.4% | +100.6% | +1.2% | +7.3% | +7.9% | +13.0% | +9.2% | +2.9% | +14.7% | +4.5% | |
| – | +15.7% | +16.4% | +55.6% | +4.5% | -10.7% | +52.5% | +18.0% | -2.7% | -2.8% | +25.1% | +2.8% | |
| – | -22.7% | +20.3% | +151.0% | +5.4% | -49.7% | +242.9% | +22.6% | -27.4% | -30.8% | +37.6% | -11.0% | |
| – | -22.7% | +20.3% | +151.0% | +5.4% | -49.7% | +242.9% | +22.6% | -27.4% | -30.8% | +37.6% | -11.0% | |
| – | +21.2% | +22.3% | +29.9% | +7.0% | +3.4% | +16.9% | +12.6% | +6.1% | +8.8% | +16.7% | +4.0% | |
| – | +8.0% | +12.4% | +56.2% | -3.5% | +6.8% | +21.8% | +8.3% | +16.9% | +5.3% | +17.6% | +9.3% | |
| – | +5.5% | +10.7% | +95.1% | +7.0% | +92.6% | +4.1% | +11.6% | +21.2% | – | – | – | |
| – | +8.4% | +10.5% | +115.2% | +1.1% | +0.6% | +1.9% | +12.8% | +5.8% | +4.6% | +17.2% | +2.5% | |
| – | -2.4% | -10.4% | +22.7% | -7.8% | -12.9% | -0.8% | -6.8% | -3.2% | +29.6% | -16.6% | -10.3% | |
| – | +28.7% | +9.4% | +100.6% | +1.2% | -29.0% | +14.2% | +0.7% | -11.0% | +3.4% | +21.1% | +10.8% | |
| – | +28.2% | +3.0% | +62.3% | +15.3% | +14.0% | +39.9% | -3.6% | -8.1% | +6.0% | +19.4% | -1.4% | |
| – | +27.8% | -1.5% | +111.1% | -5.3% | +67.8% | +11.0% | -3.0% | -1.2% | +11.7% | +28.4% | -0.3% | |
| – | +5.3% | +9.8% | +70.2% | -1.7% | +16.1% | +3.6% | +24.7% | +21.4% | +13.3% | +21.5% | +0.0% | |
| – | -8.3% | +15.2% | +50.6% | +6.6% | +11.2% | +10.6% | +3.1% | -11.1% | +5.6% | +21.0% | +10.2% | |
| – | – | – | +6,665.8% | -38.2% | +71.0% | -20.5% | +98.0% | +83.5% | -0.6% | -9.9% | -4.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -22.2% | +28.6% | +1.7% | -2.0% | +0.5% | +1.0% | +48.5% | +27.0% | +36.6% | +0.4% | +0.9% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.